South Korea’s economy is expected to grow by 4.5% this year, down from 5% last year. Last year, approximately 300,000 new jobs were created in the country, falling short of a goal of 350,000 jobs. To increase the number of jobs, ramp up investments and spur R&D activities, government will partner with the industry. The […]
New York, NY 2/13/07; Carlsbad, CA 2/13/07—Invitrogen has agreed to sell BioReliance to private equity firm Avista Capital for $210 million. BioReliance, a contract service organization providing biological safety testing, toxicology, viral manufacturing and laboratory animal diagnostic services, has annual revenues of $110 million and provides services to more than 600 clients per year. Tim […]
Grand Rapids, MI 2/8/07; Amersham, UK 2/8/07—Halma has acquired X-Rite’s Labsphere business for $13.9 million in cash and a deferred cash consideration of $1.5 million. Labsphere is a designer and manufacturer of light testing and measurement products, as well as specialized optical coatings. The company posted 2006 revenues of $12.5 million and an operating profit […]
The fiscal 2007 federal budget was finally signed into law by President Bush on February 15. The law makes permanent most of the funding amounts in the continuing resolution passed by Congress in December 2006 that essentially froze agency and program budgets at fiscal 2006 levels. However, Congress did provide funding increases for selected programs […]
Company Announcements Alpha Technologies Services, a Roper Industries company, signed an exclusive distribution agreement with AFA Technologies (Instruments) Shanghai for China, effective October 1, 2006. ADMET entered the Indian market with its universal testing machines, as well as other products, in October 2006. It sells direct and through representatives. In fall 2006, Q-Sense AB, the […]
According to the FDA, 10% of drugs in the world are counterfeit. The World Health Organization (WHO) takes a more nuanced view: according to the organization, less than 1% of drugs in developed nations are counterfeit, but 10% of drugs in developing economies are counterfeit. However, in parts of Latin America, Southeast Asia and sub-Saharan […]
Major restructurings of R&D operations were announced earlier this year by two of the world’s largest pharmaceutical companies, Pfizer and Roche. Such announcements are becoming more common for so-called “big pharma” (see IBO 4/15/05, 4/15/06), as many of the world’s 10 largest drug firms struggle to maintain historical levels of profitability during a period of […]
Santa Clara, CA 2/1/07—Intevac has acquired the assets and certain liabilities of Raman spectroscopy company DeltaNu for an undisclosed amount. Intevac is a developer of low light imaging sensors, cameras and systems and a supplier of magnetic media supporting equipment. Based in Laramie, Wyoming, DeltaNu’s products include handheld and benchtop Raman spectroscopy instruments and Raman […]
R&D activities in India have been booming: while the country only spent $2.9 billion on R&D in 2001, by 2004, this figure reached $24 billion. R&D spending is expected to reach $27.5 billion by 2010, and swell to $119 billion—2.7% of India’s estimated GDP—by 2020. There are currently 130 domestic firms and 220 multinational companies […]
The Environmental Protection Agency (EPA) announced regulations last week that will lower airborne pollutants over the next 25 years. Most significantly for oil refineries, the rules require that benzene levels be cut. On average, benzene made up roughly 1% of US gas in 2004. This proportion will be brought down to an average of 0.62% […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
